NCT01706666View on ClinicalTrials.gov

Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 7, 2012

Primary Completion Date

July 10, 2014

Study Completion Date

May 17, 2016

Conditions
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Interventions
DRUG

bortezomib

Given SC

DRUG

cyclophosphamide

Given PO

DRUG

lenalidomide

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

DRUG

dexamethasone

Given PO

PROCEDURE

quality-of-life assessment

Ancillary studies

Trial Locations (4)

63110

Washington University School of Medicine, St Louis

75042

Baylor Medical Center, Garland

85259

Mayo Clinic in Arizona, Scottsdale

21287-8936

Johns Hopkins University, Baltimore

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER